Study to Evaluate the Impact of the Recovery Pathway on Postoperative Leght of Stay in Coronary Artery Bypass Surgery
Launched by UNIVERSITY OF SAO PAULO GENERAL HOSPITAL · Nov 26, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new way to help patients recover faster after heart surgery, specifically coronary artery bypass grafting (CABG). Researchers want to see if using a special recovery plan can help patients spend less time in the hospital compared to the usual care. The trial will involve two groups of patients: one group will follow this rapid recovery protocol, while the other will receive standard care. The goal is to find out if the rapid recovery plan makes a difference in how long patients stay in the hospital, as well as their overall health, satisfaction, and costs associated with their care.
To participate in this trial, you need to be an adult (over 18 years old) and scheduled for elective or urgent CABG surgery. However, patients with certain serious health issues, like severe heart or kidney problems, or those needing emergency surgery, won't be eligible. If you join the study, you can expect close monitoring and support as you recover, and your experience will help improve care for future patients. This trial is important because it aims to enhance recovery after surgery within Brazil's public healthcare system, ultimately benefiting many patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult patients (\>18 years old)
- • Undergoing isolated coronary artery bypass grafting (CABG) with elective or urgent status
- • Signed informed consent form (ICF)
- Exclusion Criteria:
- • Emergency patients
- • Severe ventricular dysfunction (ejection fraction \<30%)
- • Renal impairment (creatinine clearance \<30 mL/min)
- • Atrial fibrillation or need for oral anticoagulation
- • Moderate-to-severe anemia (hematocrit \<32%)
- • STS risk score \>4%
- • Patient and/or family disagreement with the protocol
- • Failure to sign the informed consent form
About University Of Sao Paulo General Hospital
The University of São Paulo General Hospital (Hospital das Clínicas da Universidade de São Paulo) is a leading clinical research institution in Brazil, renowned for its commitment to advancing medical knowledge and patient care. As an academic hospital affiliated with one of the largest and most prestigious universities in Latin America, it integrates clinical practice, education, and research. The hospital conducts a wide array of clinical trials across various medical disciplines, aiming to develop innovative therapies and improve healthcare outcomes. With a multidisciplinary team of healthcare professionals and access to cutting-edge facilities, the University of São Paulo General Hospital is dedicated to fostering scientific advancements and addressing critical health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
São Paulo, , Brazil
Patients applied
Trial Officials
Gabrielle B Borgomoni, bsc, PhD student
Principal Investigator
Instituto do coração
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported